Castle Creek Arbitrage’s Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share LGV.WS Stock Holding History
Bought
Maintained
Sold
Castle Creek Arbitrage's LGV.WS Position: Q4 2022 in Review
Castle Creek Arbitrage sold out of Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share (LGV.WS) in Q4 2022, closing a stake of 41,859 shares — an estimated $3K sold.
Castle Creek Arbitrage first reported a position in LGV.WS in Q2 2021 and held it in 6 quarters. The position peaked at $57K in Q2 2021. 0 funds tracked by Wall St. Rank hold LGV.WS as of Q4 2022.
- Castle Creek Arbitrage reported no remaining Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share position as of Q4 2022 after selling out during the quarter.
- Castle Creek Arbitrage sold 41,859 Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share shares in Q4 2022, an estimated $3K.
- Castle Creek Arbitrage first reported a position in Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share in Q2 2021 and held it in 6 quarters.
- Castle Creek Arbitrage's Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share position peaked at $57K in Q2 2021.
- 0 funds tracked by Wall St. Rank held Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share as of Q4 2022.
Based on Castle Creek Arbitrage's 13F filing for Q4 2022, filed 14 Feb 2023.